Porta, Massimo

Global prevalence and major risk factors of diabetic retinopathy

Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 4,985

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-PROTECT 2): A randomised placebo-controlled trial

Sjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet

Retinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

Cited by 435

Sleep abnormalities in type 2 diabetes may be associated with glycemic control

Trento, M., Broglio, F., Riganti, F., Basile, M., Borgo, E., Kucich, C., Passera, P., Tibaldi, P., Tomelini, M., Cavallo, F., et al. (2008) · Acta Diabetologica

Sleep and related disordersCircadian rhythm and melatonin

Cited by 104

A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes

Trento, M., Raballo, M., Trevisan, M., Sicuro, J., Passera, P., Cirio, L., Charrier, L., Cavallo, F., & Porta, M. (2012) · Acta Diabetologica

Diabetes Management and EducationMental Health Treatment and Access

Cited by 60

Peripheral neuropathy after viral eradication with direct‐acting antivirals in chronic HCV hepatitis: A prospective study

Zanone, M. M., Marinucci, C., Ciancio, A., Cocito, D., Zardo, F., Spagone, E., Ferrero, B., Cerruti, C., Charrier, L., Cavallo, F., et al. (2021) · Liver International

Hepatitis C virus researchPeripheral Neuropathies and Disorders

Cited by 19